TUESDAY, Dec. 7, 2021 (HealthDay News) — President Joe Biden promised cheaper prescription drugs for all Americans on Monday as his social agenda legislation winds its way through Congress. Biden tried to shift Americans’ focus to pocketbook provisions overlooked in his $2 trillion legislation, which deals with everything from climateContinue Reading

TUESDAY, Dec. 7, 2021 (HealthDay News) — The best available treatment for COVID-19 infection just got a lot easier to administer to more people, potentially saving more lives in the process, a new study claims. Monoclonal antibodies have been shown to dramatically reduce risk of hospitalization and death if givenContinue Reading

TUESDAY, Dec. 7, 2021 (HealthDay News) — Yet another study shows that a combination of vaccination and previous infection may provide better protection against new COVID-19 variants than either one alone. That’s because the antibodies a person develops after either just vaccination or previous infection may not be able toContinue Reading

MONDAY, Dec. 6, 2021 (HealthDay News) — It happens very rarely, but most teens and young adults who do experience heart inflammation (myocarditis) after a COVID-19 shot have mild symptoms and recover quickly, new research shows. “Overwhelmingly, data continue to indicate that the benefits of COVID-19 vaccination — 91% effectiveContinue Reading

SUNDAY, Dec. 5, 2021 (HealthDay News) — If you’re a patient with a weakened immune system, roll up your sleeves to stay safe over the holidays and winter months. “Immunocompromised patients absolutely should get a flu shot as well as an additional COVID-19 vaccine dose,” said Dr. Marwa Kaisey, aContinue Reading

FRIDAY, Dec. 3, 2021 (HealthDay News) — People who’ve already had COVID-19 have a higher risk of reinfection with the Omicron coronavirus variant than with earlier variants, new research shows. The South African scientists who reported the findings believe that vaccination will have the power to stop severe illness, however.Continue Reading

FRIDAY, Dec. 3, 2021 (HealthDay News) — Women are two times more likely than men to die after receiving a combination of cancer immunotherapy drugs called checkpoint inhibitors, but it’s not clear if that difference is due to side effects or because the treatment isn’t working, researchers say. This newContinue Reading